| scholarly article | Q13442814 |
| P2093 | author name string | Bing Ren | |
| Yan Li | |||
| Rama Natarajan | |||
| Jiing-Kuan Yee | |||
| Marpadga A Reddy | |||
| David Hawkins | |||
| Feng Miao | |||
| Narkunaraja Shanmugam | |||
| P2860 | cites work | Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation | Q36076678 |
| Thematic review series: The immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease. | Q36099980 | ||
| Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes | Q40163092 | ||
| Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells | Q40285881 | ||
| Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products | Q44499434 | ||
| Growth factors induce monocyte binding to vascular smooth muscle cells: implications for monocyte retention in atherosclerosis | Q44894343 | ||
| Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells | Q46468830 | ||
| Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice | Q47590797 | ||
| Catalytic mechanism and product specificity of the histone lysine methyltransferase SET7/9: an ab initio QM/MM-FE study with multiple initial structures. | Q52568420 | ||
| RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 | ||
| Translating the Histone Code | Q22065840 | ||
| Structural basis for the methylation site specificity of SET7/9 | Q24301341 | ||
| Regulation of p53 activity through lysine methylation | Q24311514 | ||
| Gene-specific modulation of TAF10 function by SET9-mediated methylation | Q24337399 | ||
| Atherosclerosis | Q24644573 | ||
| Structural basis for the product specificity of histone lysine methyltransferases | Q24646957 | ||
| Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation | Q24672514 | ||
| The SET-domain protein superfamily: protein lysine methyltransferases | Q24811144 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Crystal structure and functional analysis of the histone methyltransferase SET7/9 | Q27639758 | ||
| Chromatin modifications and their function | Q27861067 | ||
| NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses | Q27861101 | ||
| The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing | Q28116655 | ||
| The complex language of chromatin regulation during transcription | Q28131748 | ||
| Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome | Q28131828 | ||
| Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17 | Q28298956 | ||
| Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression | Q28512283 | ||
| Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9 | Q28594945 | ||
| Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 | Q28619230 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| IKK-beta links inflammation to obesity-induced insulin resistance | Q29614285 | ||
| The diverse functions of histone lysine methylation | Q29614523 | ||
| Multivalent engagement of chromatin modifications by linked binding modules | Q29617236 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control | Q29620172 | ||
| Pdx-1 links histone H3-Lys-4 methylation to RNA polymerase II elongation during activation of insulin transcription | Q30437951 | ||
| Role of smooth muscle cells in the initiation and early progression of atherosclerosis | Q30438867 | ||
| Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. | Q34108153 | ||
| In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions | Q34300068 | ||
| Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation | Q35131664 | ||
| Transcriptional elongation by RNA polymerase II and histone methylation | Q35134912 | ||
| Nuclear factor kappaB signaling in atherogenesis. | Q36054434 | ||
| P4510 | describes a project that uses | limma | Q112236343 |
| P433 | issue | 39 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| NF-κB | Q411114 | ||
| P304 | page(s) | 26771-26781 | |
| P577 | publication date | 2008-07-23 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation | |
| P478 | volume | 283 |
| Q34144669 | (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells |
| Q34637809 | A NF-κB-dependent dual promoter-enhancer initiates the lipopolysaccharide-mediated transcriptional activation of the chicken lysozyme in macrophages |
| Q38137567 | A journey toward Bioorthogonal Profiling of Protein Methylation inside living cells |
| Q28389552 | Aberrant 5'-CpG Methylation of Cord Blood TNFα Associated with Maternal Exposure to Polybrominated Diphenyl Ethers |
| Q54347680 | Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata. |
| Q33640900 | Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis |
| Q28579534 | Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC) |
| Q33694925 | Adenosine 5'-monophosphate ameliorates D-galactosamine/lipopolysaccharide-induced liver injury through an adenosine receptor-independent mechanism in mice |
| Q37707727 | Alteration of histone H3 lysine 9 dimethylation in peripheral white blood cells of septic patients with trauma and cancer |
| Q36197219 | Astragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages |
| Q34340360 | Atherogenic factors and their epigenetic relationships |
| Q61829990 | Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer |
| Q92855414 | Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus? |
| Q33751386 | Chemical probes targeting epigenetic proteins: Applications beyond oncology |
| Q38199995 | Chromatin dynamics: H3K4 methylation and H3 variant replacement during development and in cancer. |
| Q38013734 | Chromatin modifications associated with diabetes |
| Q37983159 | Chronic pain: emerging evidence for the involvement of epigenetics |
| Q24300761 | Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes |
| Q38770693 | Critical Link Between Epigenetics and Transcription Factors in the Induction of Autoimmunity: a Comprehensive Review |
| Q29617418 | Crosstalk in NF-κB signaling pathways |
| Q26995430 | Current chemical biology approaches to interrogate protein methyltransferases |
| Q38476540 | Deep sequencing reveals novel Set7 networks. |
| Q34028239 | Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4. |
| Q38227252 | Diabetic nephropathy--emerging epigenetic mechanisms |
| Q34796061 | Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures |
| Q39725004 | Dietary phenolic acids attenuate multiple stages of protein glycation and high-glucose-stimulated proinflammatory IL-1beta activation by interfering with chromatin remodeling and transcription in monocytes |
| Q38093421 | Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart? |
| Q47715778 | Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads |
| Q37383323 | Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats |
| Q58049788 | Endothelial Transcriptome in Response to Pharmacological Methyltransferase Inhibition |
| Q34237731 | Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. |
| Q38845518 | Epigenetic Changes in Diabetes and Cardiovascular Risk. |
| Q26859263 | Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications |
| Q36656799 | Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy |
| Q38777244 | Epigenetic Regulation of Monocyte and Macrophage Function |
| Q44370140 | Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes |
| Q38107626 | Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation |
| Q55266134 | Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages. |
| Q35036368 | Epigenetic gene regulation in the adult mammalian brain: multiple roles in memory formation |
| Q28579049 | Epigenetic histone methylation modulates fibrotic gene expression |
| Q44858633 | Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. |
| Q35071700 | Epigenetic mechanisms in diabetic complications and metabolic memory |
| Q34986508 | Epigenetic mechanisms in diabetic vascular complications |
| Q26822513 | Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition |
| Q36471772 | Epigenetic modifications and diabetic nephropathy. |
| Q37158080 | Epigenetic modifications in the pathogenesis of diabetic nephropathy |
| Q37806609 | Epigenetic phenomena linked to diabetic complications. |
| Q93264969 | Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy |
| Q47564897 | Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration |
| Q35991082 | Epigenetic regulation of cytokine production in human amnion and villous placenta. |
| Q39676602 | Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin |
| Q57045390 | Epigenetics Variation and Pathogenesis in Diabetes |
| Q35867015 | Epigenetics and autoimmune diseases. |
| Q92512595 | Epigenetics and epigenomics in diabetic kidney disease and metabolic memory |
| Q41991194 | Epigenetics and trained immunity. |
| Q37446658 | Epigenetics in adipose tissue, obesity, weight loss, and diabetes |
| Q88453278 | Epigenetics of Aberrant Cardiac Wound Healing |
| Q28079434 | Epigenetics of Renal Development and Disease |
| Q37200532 | Epigenetics of diabetic complications |
| Q42030420 | Epigenetics: Tools and Technologies |
| Q24652830 | Epigenetics: a molecular link between environmental factors and type 2 diabetes |
| Q35068854 | Epigenetics: deciphering its role in diabetes and its chronic complications |
| Q37715576 | Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. |
| Q34625920 | Fetal environment, epigenetics, and pediatric renal disease |
| Q39410846 | Gene networking and inflammatory pathway analysis in a JMJD3 knockdown human monocytic cell line |
| Q38829133 | Glucose-induced expression of the homeotic transcription factor Prep1 is associated with histone post-translational modifications in skeletal muscle |
| Q35696490 | Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression |
| Q39339392 | Heterochromatin protein 1 gamma and IκB kinase alpha interdependence during tumour necrosis factor gene transcription elongation in activated macrophages. |
| Q36924772 | Histone Lysine Methylation in TGF-β1 Mediated p21 Gene Expression in Rat Mesangial Cells. |
| Q92187905 | Histone Methyltransferases as Therapeutic Targets for Kidney Diseases |
| Q39164317 | Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes. |
| Q35836643 | Histone methylation levels correlate with TGFBIp and extracellular matrix gene expression in normal and granular corneal dystrophy type 2 corneal fibroblasts |
| Q39340075 | Histone methyltransferase NSD2/MMSET mediates constitutive NF-κB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop |
| Q28476709 | Histone variants and their post-translational modifications in primary human fat cells |
| Q89207832 | Histones and heart failure in diabetes |
| Q38320756 | Human genetics of diabetic nephropathy |
| Q38247113 | Human genetics of diabetic retinopathy |
| Q27000709 | Human genetics of diabetic vascular complications |
| Q33673500 | Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways. |
| Q49533652 | IL-13 regulates human nasal epithelial cell differentiation via H3K4me3 modification. |
| Q52719421 | Immune senescence, epigenetics and autoimmunity. |
| Q36018745 | Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma |
| Q38740496 | Inhibitors of Protein Methyltransferases and Demethylases. |
| Q42182620 | Interaction of SET domains with histones and nucleic acid structures in active chromatin. |
| Q91302959 | Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases |
| Q92662145 | Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity |
| Q41939992 | Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice |
| Q30300978 | Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway |
| Q38830359 | Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathway |
| Q38706561 | Lysine methylation of promoter-bound transcription factors and relevance to cancer |
| Q37970950 | Lysine methylation: beyond histones |
| Q38715627 | MKL1 is an epigenetic mediator of TNF-α-induced proinflammatory transcription in macrophages by interacting with ASH2. |
| Q36205231 | Metabolic memory and chronic diabetes complications: potential role for epigenetic mechanisms |
| Q37737556 | Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms |
| Q40049632 | Metabolic orchestration of T lineage differentiation and function |
| Q30437467 | Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes |
| Q28483894 | NF-κB repression by PIAS3 mediated RelA SUMOylation |
| Q24317508 | Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit |
| Q37368629 | Negative regulation of interferon-induced transmembrane protein 3 by SET7-mediated lysine monomethylation |
| Q37598306 | New insights into molecular mechanisms of diabetic kidney disease |
| Q26830607 | Nitric oxide, oxidative stress, and p66Shc interplay in diabetic endothelial dysfunction |
| Q26829684 | Nutrition, epigenetics, and metabolic syndrome |
| Q37151820 | Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases. |
| Q34750033 | PU.1 and C/EBP(alpha) synergistically program distinct response to NF-kappaB activation through establishing monocyte specific enhancers |
| Q38592178 | Post-translational control of transcription factors: methylation ranks highly |
| Q43196259 | Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. |
| Q34059822 | Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines |
| Q37590090 | Protein methyltransferases as a target class for drug discovery |
| Q42608215 | Proteomic Study to Survey the CIGB-552 Antitumor Effect |
| Q39432945 | Quercetin Inhibits Peripheral and Spinal Cord Nociceptive Mechanisms to Reduce Intense Acute Swimming-Induced Muscle Pain in Mice |
| Q38837814 | Quercus infectoria inhibits Set7/NF-κB inflammatory pathway in macrophages exposed to a diabetic environment |
| Q36787367 | RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles |
| Q36162576 | Refinement of the HIVAN1 Susceptibility Locus on Chr. 3A1-A3 via Generation of Sub-Congenic Strains |
| Q35094641 | Regulation of Mcl-1 by constitutive activation of NF-κB contributes to cell viability in human esophageal squamous cell carcinoma cells |
| Q37404711 | Regulation of NF-kappaB activity through lysine monomethylation of p65. |
| Q34545552 | Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA. |
| Q39642231 | Regulation of the androgen receptor by SET9-mediated methylation |
| Q39362468 | Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D. |
| Q38059670 | Role of epigenetic mechanisms in the vascular complications of diabetes. |
| Q37615671 | SET for life: biochemical activities and biological functions of SET domain-containing proteins |
| Q35860498 | SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β Cell |
| Q37580675 | SET7/9 mediated methylation of non-histone proteins in mammalian cells |
| Q35006936 | SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress |
| Q37715321 | Selective transcription in response to an inflammatory stimulus |
| Q53259459 | Spinal SET7/9 may contribute to the maintenance of cancer-induced bone pain in mice. |
| Q48377058 | Stress-associated H3K4 methylation accumulates during postnatal development and aging of rhesus macaque brain |
| Q27659033 | Structural Biology of Human H3K9 Methyltransferases |
| Q37071609 | Sulforaphane attenuates the development of atherosclerosis and improves endothelial dysfunction in hypercholesterolemic rabbits |
| Q33865037 | Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. |
| Q36577968 | Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block |
| Q93139190 | Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics |
| Q48134991 | Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers. |
| Q37941687 | Targets in epigenetics: inhibiting the methyl writers of the histone code |
| Q39777846 | The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. |
| Q33548737 | The role of NF-kappaB and H3K27me3 demethylase, Jmjd3, on the anthrax lethal toxin tolerance of RAW 264.7 cells |
| Q24609124 | The role of epigenetics in the pathology of diabetic complications |
| Q37461601 | Transcription factors in the pathogenesis of diabetic nephropathy |
| Q35352055 | Transcriptional activity of the islet β cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. |
| Q37696067 | Transcriptional control of the TNF gene |
| Q27009508 | Transcriptional regulation by the Set7 lysine methyltransferase |
| Q88117680 | Transient epigenomic changes during pregnancy and early postpartum in women with and without type 2 diabetes |
| Q28068273 | Transition from inflammation to proliferation: a critical step during wound healing |
| Q37411672 | Understanding the epigenetic syntax for the genetic alphabet in the kidney |
| Q39387287 | t-AUCB, an improved sEH inhibitor, suppresses human glioblastoma cell growth by activating NF-κB-p65. |
Search more.